120 related articles for article (PubMed ID: 31737117)
1. The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma.
Xia J; Zhu HY; Liang JH; Ding CY; Wang L; Wu W; Cao L; Li TL; Li JY; Xu W
J Cancer; 2019; 10(23):5805-5811. PubMed ID: 31737117
[No Abstract] [Full Text] [Related]
2. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.
Kim CY; Hong CM; Kim DH; Son SH; Jeong SY; Lee SW; Lee J; Ahn BC
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1321-9. PubMed ID: 23674211
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M
Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of
Choi EK; Park M; Im JJ; Chung YA; Oh JK
J Int Med Res; 2020 Apr; 48(4):300060519892419. PubMed ID: 31880209
[TBL] [Abstract][Full Text] [Related]
5. Associations of whole-body 18F-FDG PET/CT parameters and SCC-Ag level with overall survival in patients with cervical cancer.
Guan L; Zuo R; Wang Z; Xu L; Liu S; Pang H
Nucl Med Commun; 2022 Jan; 43(1):49-55. PubMed ID: 34887369
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metabolic parameters measured by
Mathew B; Purandare NC; Puranik A; Shah S; Agrawal A; Pramesh CS; Karimundackal G; Jiwnani S; Rangarajan V
World J Nucl Med; 2020; 19(1):8-14. PubMed ID: 32190016
[No Abstract] [Full Text] [Related]
7. Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer.
Mayoral M; Fernandez-Martinez A; Vidal L; Fuster D; Aya F; Pavia J; Pons F; Lomeña F; Paredes P
Rev Esp Med Nucl Imagen Mol; 2016; 35(2):88-95. PubMed ID: 26541072
[TBL] [Abstract][Full Text] [Related]
8. The ratio between the whole-body and primary tumor burden, measured on
Oliveira FRA; Santos AO; de Lima MDCL; Toro IFC; de Souza TF; Amorim BJ; Barbeiro AS; Etchebehere E
Radiol Bras; 2021; 54(5):289-294. PubMed ID: 34602663
[TBL] [Abstract][Full Text] [Related]
9. Utility of baseline, interim and end-of-treatment
Chang Y; Fu X; Sun Z; Xie X; Wang R; Li Z; Zhang X; Sheng G; Zhang M
Sci Rep; 2017 Jan; 7():41057. PubMed ID: 28117395
[TBL] [Abstract][Full Text] [Related]
10. Predicting epithelial ovarian cancer prognosis: correlation of posttreatment
Yang L; Li M; Liang H; Wang X; Guan L; Jing X
Quant Imaging Med Surg; 2024 Jan; 14(1):972-985. PubMed ID: 38223064
[TBL] [Abstract][Full Text] [Related]
11. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J
Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
[TBL] [Abstract][Full Text] [Related]
12. Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer.
Liao S; Lan X; Cao G; Yuan H; Zhang Y
Clin Nucl Med; 2013 Sep; 38(9):715-20. PubMed ID: 23856825
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Nasopharyngeal Carcinoma Patients after Comprehensive Therapy.
Tian Y; Bakari KH; Liao S; Xia X; Sun X; Qin C; Zhang Y; Lan X
Contrast Media Mol Imaging; 2018; 2018():1384281. PubMed ID: 29681779
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
16. Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL).
Jiang C; Teng Y; Chen J; Wang Z; Zhou Z; Ding C; Xu J
EJNMMI Res; 2020 Sep; 10(1):110. PubMed ID: 32965554
[TBL] [Abstract][Full Text] [Related]
17. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082
[TBL] [Abstract][Full Text] [Related]
18. Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric Lymphoma.
Etchebehere E; Andrade R; Camacho M; Lima M; Brink A; Cerci J; Nadel H; Bal C; Rangarajan V; Pfluger T; Kagna O; Alonso O; Begum FK; Mir KB; Magboo VP; Menezes LJ; Paez D; Pascual TN
J Nucl Med Technol; 2022 Sep; 50(3):256-262. PubMed ID: 35440476
[No Abstract] [Full Text] [Related]
19. Prognostic value of 18F-FDG lesion dissemination features in patients with peripheral T-cell lymphoma (PTCL).
Xie Y; Teng Y; Jiang C; Ding C; Zhou Z
Jpn J Radiol; 2023 Jul; 41(7):777-786. PubMed ID: 36752954
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
